Biopharma Reports Fifth Quarter of Increased Net Revenues
AllpennyStocks.com

Biopharma Reports Fifth Quarter of Increased Net Revenues

By: Tomas Ronolski - AllPennyStocks.com News

Monday, May 15, 2023

Those afflicted with sickle cell disease face many challenges and acute complications. This biopharma company is the leader in treatment of the disease and just reported its fifth straight increase in quarterly net revenues. 

Emmaus Life Sciences, Inc. (OTCQX: EMMA) reported on its financial condition and results of operations as of and for the three months ended March 31, 2023. Increased sales in the U.S. and Middle East/North Africa region helped the firm report a fifth straight increase in quarterly net revenues and increased net revenues of 109% year-over-year. 

Due to these increases the firm was able to substantially reduce losses from operations and realized income from operations excluding share-based compensation. The firm’s product, Endari® (L-glutamine oral powder), is indicated to reduce the acute complications of sickle cell disease in adults and children 5 years and older, is approved for marketing in the United States, Israel, Kuwait, Qatar and the United Arab Emirates and is available on a named patient or early access basis in France, the Netherlands. Shares last traded at $0.32.


Copyright © 2023 AllPennyStocks.com. All rights reserved. Republication or redistribution of AllPennyStocks.com's content is expressly prohibited without the prior written consent of AllPennyStocks.com. AllPennyStocks.com shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Other Penny Stock Movers

Canadian Manufacturing and Wholesale Sales Point to Weakening Economy and Raise Possibilities of Rate Cuts
 Read More
Drill Less, Extract More: This Just Announced Merger Unlocks Profits
 Read More
100,000,000 Euro Commitment Sends Shares of this MicroCap Hydrogen Automaker Soaring
 Read More
Most Popular
1
Drill Less, Extract More: This Just Announced Merger Unlocks Profits
2
Re-Classification of Marijuana Sends Shares of Cannabis Operator on a Tear
3
Canadian Manufacturing and Wholesale Sales Point to Weakening Economy and Raise Possibilities of Rate Cuts
4
Industrial Safety Leader Announces Expansion Sending Shares Higher
5
A Loss at Mercedes-Benz Slows U.A.W.’s Southern Campaign
6
What’s BlackRock Without Larry Fink? Shareholders Fret About Future.
FREE Newsletter
AllPennyStocks.com Favorites


Back to Top
Site Links:
Premium Services / Email Newsletter:
Social Media:
RSS Feed:
Partners:
© Copyright 2024 AllPennyStocks.com Media Inc. All rights reserved. Nasdaq Stocks: Information delayed 15 minutes. Non-Nasdaq Stocks: Information delayed 20 minutes.
Bid and Ask quotation information for NYSE and AMEX securities is only available on a real time basis. Data is provided by QuoteMedia.com.
© Copyright 1999 – 2024. AllPennyStocks.com Media Inc.
All rights reserved.